Recent data from Cancer Research UK suggest that of those patients diagnosed in 2010/11 over 50% will become long-term survivors. Even those patients not cured now experience increasing survival with advanced cancer. With an ageing population there will be increased numbers of cancer survivors in the UK, 2 million in 2010 rising to 4 million by 2030. There are increasing numbers of very long term survivors of cancer. Moreover, the needs of these cancer survivors are further complicated by the age-associated increase in co morbidity” (ACP Strategy for Improving Services and Outcomes for Cancer Patients, 2015).
Cancer survivorship is a strategic focus for the ACP and the Royal College of Physicians is hosting a 1-day conference that will focus on the 'medical' late effects of cancer treatments.
This conference was nominated by the ACP/Joint Specialty Committee and will provide a forum to discuss best practice between medical oncologists and our physicianly colleagues and therefore we support what promises to be an excellent conference
- scale and nature, and the patient's perspective of the problem
- the systemic effects of cancer treatment – endocrine, respiratory, cardiac and exercise
- bone metabolism
- research in late effects
- cancer as a chronic disease
- how to do late effects of cancer treatment care well.
Visit here for more details